Navigation Links
Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
Date:5/20/2008

LOS ANGELES, May 20 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE). Ross Silver, Director of Research of Vista Partners stated, "Alseres' recombinant-protein-based drug named Cethrin has shown highly encouraging clinical and preclinical data to date. Cethrin would serve a multi-billion dollar market if approved. In addition to Cethrin, Alseres has a molecular imaging program in Phase III clinical trials, a program we believe will likely be partnered within the next 12 months. Alseres is a highly attractive investment at its current valuation." To download a free copy of the report, please visit the Vista Partners website, http://www.vistap.com and click on the download research icon.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff has backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Alseres Pharmaceuticals, Inc.:

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initi
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
2. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
3. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
5. Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
6. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
7. Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
8. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
9. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
10. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
11. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... The University of Rochester Medical Center (URMC...inistration (FDA) to develop a national repository...rchers studying the electrical activity of the hea...many cardiac problems, the data may aid the develo...angerous effects on the heart. , The repositor...
(Date:7/9/2008)... DALLAS, July 9 /PRNewswire-FirstCall/ -- The M...nternational conference as leaders from around the...stem could be transformed,into an innovative model...uter Services, Inc. (ACS) will present the forum t... technology while showcasing practical,application...
(Date:7/9/2008)... Rude language, hostile behavior threaten safet...swire-USNewswire/ -- Health care,is a high-stakes,...its of,civility in the workplace. A new alert issu...anguage and hostile behavior among health care,pro...a serious threat to,patient safety and the overall...
(Date:7/9/2008)... Additional Research Warranted on Impact of Med... Access Challenges; Data Shows Possibility of,Long...SHINGTON, July 9 /PRNewswire-USNewswire/ -- Accord...e of the Journal of the American Medical,Associati...anges in their,access to quality cancer care follo...
Breaking Medicine News(10 mins):Health News:URMC, FDA to collaborate on national data repository for heart research 2Health News:URMC, FDA to collaborate on national data repository for heart research 3Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 3Health News:Joint Commission Alert: Stop Bad Behavior Among Health Care Professionals 2Health News:Joint Commission Alert: Stop Bad Behavior Among Health Care Professionals 3Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2
...d States : A study has indicated that blood tests ...troke risk, are only as good //as cholesterol test...em, in terms of being a veritable risk indicator. ... substances in the blood which they interpreted as...
...ournal ,Nature reported a very interesting finding...iversity. //The researchers found that obese peopl...a in their gut that helps to digest food well .Sli...the same bacteria. Humans need efficient bacte...
...aboratory research suggests that lithium and other...a, should be used with caution in treating Alzheim... rather than enhance, neuronal function. Lithium ...eating Alzheimer's. Pharmaceutical companies are i...
...a: Doctors are experiencing a nationwide shortage ...idays arrive.// Earlier this month, due to shorta... Toronto, more skin had flown from Calgary for tre...n more than 80% of his body. Skin, one of the bo...
Other Medicine News:Health News:Intestinal Bacteria Blamed for Rotund Figures 2Health News:High Doses of Lithium-Like Drugs May Impair Neuronal Function 2
(Date:7/7/2008)...Call/ -- Biopure Corporation,(Nasdaq: BPUR ) anno...ood,and Drug Administration (FDA) on identifying a... trial of Hemopure(R) [hemoglobin glutamer -,250 (...dy use of Hemopure,in patients suffering from Acut...n with blood components. Currently, AML patients w...
(Date:7/6/2008)...d for FDA Clearance, SAN DIEGO, July 7 /PRNewswir...ecton, Dickinson and Company) (NYSE: BDX ), annou...iff molecular assay for the rapid diagnosis,of pat...It is the first CDI,diagnostic test that offers se...ure. BD has also submitted this assay to the U.S. ...
(Date:7/3/2008)...ire/ -- All newborn infants,should be screened for...,according to a new recommendation from the U.S. P...and the accompanying summary of evidence appear,in...hearing is impaired at birth, during infancy or in... nonverbal communication and,social skills, increa...
(Date:7/2/2008)...n August -, EXTON, Pa., July 2 /PRNewswire-FirstC...oday the completion of the pivotal efficacy portio... investigating the Isolagen,Therapy(TM) for the tr...,person in each study has completed the primary ef... has begun. The Company anticipates that top-line,...
Breaking Medicine Technology:Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Tiny pest eating insect fights fruit flies 1484 1PET and bioluminescent imaging aid evaluation of stem cells potential for new ways to treat disease 7747 1PET and bioluminescent imaging aid evaluation of stem cells potential for new ways to treat disease 7747 2PET and bioluminescent imaging aid evaluation of stem cells potential for new ways to treat disease 7747 3University of British Columbia Research Shows Health Benefits of GameBike 28TM 29 7743 1University of British Columbia Research Shows Health Benefits of GameBike 28TM 29 7743 2Kentucky Pharmacists Urge Senator McConnell to Put Patients First 7739 1Kentucky Pharmacists Urge Senator McConnell to Put Patients First 7739 2Kentucky Pharmacists Urge Senator McConnell to Put Patients First 7739 3
...Demonstrates Significant,Additional Improvement fo..., 2007 /PRNewswire-FirstCall/ --,Indevus Pharmaceu...,Company,s Phase II EXPRESS trial for pagoclone in...nted today at the 47th annual,meeting of the New C... National Institute for Mental Health (NIMH) and b...
... help women,learn about breast cancer therapy adva...g to a new,GfK Roper Public Affairs survey sponsor...ort organization, while the majority (76,percent) ...mount,about breast cancer, many remain unaware of ...ewer than one out of four (23 percent),women ages ...
Other Medicine Technology:Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 2Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 3
Rapid reagent impregnated disk test for presumptive identification of Candida albicans.
...sive Electronic Medical Records for small and larg...tient flow from check-in to check-out. Review the ...rent medications, to allergies, labs and charts al...ecords immediately. Communicate electronically wit...
Written specifically for urologists by a urologist, this EMR software utilizes touch screen technology to streamline your workflow and virtually eliminate the use of a cumbersome mouse. Its intuitive
...t Record is a new generation of advanced Electroni...the largest, numerically codified medical vocabula... data elements embedded in MedcomSoft Record, heal... an easy and intuitive point and click system and ...
Medicine Products: